Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment

Stock Information for Soliton Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Soliton Inc.

Allergan Aesthetics Completes Acquisition of Soliton
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER ALERT: WeissLaw LLP Reminds ICBK, MCF, CLDR, and SOLY Shareholders About Its Ongoing Investigations
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MNR, CORE, MMAC, SOLY, SPRT, MFNC; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER ALERT: WeissLaw LLP Reminds SPRT, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds RBC, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, MRLN, KIM, MLHR, SOLY; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER ALERT: WeissLaw LLP Reminds RBC, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.